<html>
<head>
<title>Hormones</title>
</head>
<body>
<h1>Hormones Citations</h1>
<hr/>
<h2>Gene: CYP2R1, GC, VDR</h2>
<p><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8465200/" target="_blank">Krasniqi E, Boshnjaku A, Wagner KH, Wessner B. Association between Polymorphisms in Vitamin D Pathway-Related Genes, Vitamin D Status, Muscle Mass and Function: A Systematic Review. Nutrients. 2021 Sep 4;13(9):3109. doi: 10.3390/nu13093109. PMID: 34578986; PMCID: PMC8465200.</a></p>
<hr/>
<h2>Gene: GSTP1</h2>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/19383894/" target="_blank">Reding KW, Weiss NS, Chen C, et al. Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18(5):1461-1467. doi:10.1158/1055-9965.EPI-08-0917</a></p>
<hr/>
<h2>Gene: Estro PW</h2>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/21824047/" target="_blank">Ramos Cirilo PD, Rosa FE, Moreira Ferraz MF, Rainho CA, Pontes A, Rogatto SR. Genetic polymorphisms associated with steroids metabolism and insulin action in polycystic ovary syndrome. Gynecol Endocrinol. 2012;28(3):190-194. doi:10.3109/09513590.2011.593661</a></p>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/20432167/" target="_blank">Iwasaki M, Hamada GS, Nishimoto IN, et al. Dietary isoflavone intake, polymorphisms in the CYP17, CYP19, 17beta-HSD1, and SHBG genes, and risk of breast cancer in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians. Nutr Cancer. 2010;62(4):466-475. doi:10.1080/01635580903441279</a></p>
<hr/>
<h2>Gene: Estro Tox</h2>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/18628428/" target="_blank">Diergaarde B, Potter JD, Jupe ER, et al. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(7):1751-1759. doi:10.1158/1055-9965.EPI-08-0168</a></p>
<hr/>
<h2>Gene: CYP17A1 (prostate, race)</h2>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/21656827/" target="_blank">Wang F, Zou YF, Feng XL, Su H, Huang F. CYP17 gene polymorphisms and prostate cancer risk: a meta-analysis based on 38 independent studies. Prostate. 2011;71(11):1167-1177. doi:10.1002/pros.21332</a></p>
<hr/>
<h2>Gene: SRD5A2</h2>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/21530059/" target="_blank">Graupp M, Wehr E, Schweighofer N, Pieber TR, Obermayer-Pietsch B. Association of genetic variants in the two isoforms of 5?-reductase, SRD5A1 and SRD5A2, in lean patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2011;157(2):175-179. doi:10.1016/j.ejogrb.2011.03.026</a></p>
<hr/>
<h2>Gene: UGT2Bs</h2>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/19572376/" target="_blank">Ménard V, Eap O, Harvey M, Guillemette C, Lévesque E. Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism. Hum Mutat. 2009;30(9):1310-1319. doi:10.1002/humu.21054</a></p>
<hr/>
<h2>Gene: UGT2Bs (race)</h2>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/24267955/" target="_blank">Vidal AC, Tucker C, Schildkraut JM, et al. Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study. BMC Cancer. 2013;13:556. Published 2013 Nov 22. doi:10.1186/1471-2407-13-556</a></p>
<hr/>
<h2>Gene: UGT2Bs</h2>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/21614655/" target="_blank">Giroux S, Bussières J, Bureau A, Rousseau F. UGT2B17 gene deletion associated with an increase in bone mineral density similar to the effect of hormone replacement in postmenopausal women. Osteoporos Int. 2012;23(3):1163-1170. doi:10.1007/s00198-011-1662-6</a></p>
<hr/>
<h2>Gene: CYP19A1</h2>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/19952760/" target="_blank">Sonoda T, Suzuki H, Mori M, et al. Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men. Eur J Cancer Prev. 2010;19(2):131-137. doi:10.1097/CEJ.0b013e328333fbe2</a></p>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/20797716/" target="_blank">Kim S, Pyun JA, Kang H, Kim J, Cha DH, Kwack K. Epistasis between CYP19A1 and ESR1 polymorphisms is associated with premature ovarian failure. Fertil Steril. 2011;95(1):353-356. doi:10.1016/j.fertnstert.2010.07.1067</a></p>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/15199113/" target="_blank">Dunning AM, Dowsett M, Healey CS, et al. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst. 2004;96(12):936-945. doi:10.1093/jnci/djh167</a></p>
<hr/>
<h2>Gene: CYP1A2, CYP1B1</h2>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/17615053/" target="_blank">Bethke L, Webb E, Sellick G, et al. Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk. BMC Cancer. 2007;7:123. Published 2007 Jul 5. doi:10.1186/1471-2407-7-123</a></p>
<hr/>
<h2>Gene: CYP1B1</h2>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/18628428/" target="_blank">Diergaarde B, Potter JD, Jupe ER, et al. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(7):1751-1759. doi:10.1158/1055-9965.EPI-08-0168</a></p>
<hr/>
<h2>Gene: CYP17, CYP19A1</h2>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/23809139/" target="_blank">Szczepa?ska M, Wirstlein P, Skrzypczak J, Jagodzi?ski PP. Polymorphic variants of CYP17 and CYP19A and risk of infertility in endometriosis. Acta Obstet Gynecol Scand. 2013;92(10):1188-1193. doi:10.1111/aogs.12210</a></p>
</body>
</html>